carbostyril has been researched along with Acquired Immune Deficiency Syndrome in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Cheng, X; Wei, D; Xu, Q | 1 |
| Hu, LM; Luo, ZG; Tan, JJ; Wang, CX; Zeng, Y | 1 |
| Fricchione, GL; Huffman, JC | 1 |
| Berger, D; Cheng, AK; Cohen, C; DeJesus, E; Elion, R; Farthing, C; Hawkins, T; Kearney, BP; Markowitz, M; McColl, D; Ruane, P; Zhong, L | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Mallet, MN | 2 |
| Anstead, G; Blaser, M; Craig, F; Jorgensen, J; Patterson, T | 1 |
| Bollet, C; de Lamballerie, X; de Micco, P; Gevaudan, MJ; Mallet, MN; Sambuc, R | 1 |
| Gikas, A; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
1 review(s) available for carbostyril and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview.
Topics: Acquired Immunodeficiency Syndrome; Drug Design; HIV Integrase; Humans; Integrase Inhibitors; Quinolones; Structure-Activity Relationship; Virus Integration | 2010 |
1 trial(s) available for carbostyril and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patients.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; HIV Infections; HIV Integrase; Humans; Quinolones | 2006 |
9 other study(ies) available for carbostyril and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Cobicistat + elvitegravir + emtricitabine + tenofovir. Two new drugs, but no progress.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Carbamates; Cobicistat; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; HIV-1; Humans; Organophosphonates; Quinolones; Tenofovir; Thiazoles | 2013 |
Molecular dynamics simulation studies of the wild type and E92Q/N155H mutant of Elvitegravir-resistance HIV-1 integrase.
Topics: Acquired Immunodeficiency Syndrome; Catalytic Domain; DNA, Viral; Drug Resistance, Viral; Genotype; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Molecular Dynamics Simulation; Mutation; Quinolones | 2015 |
Catatonia and psychosis in a patient with AIDS: treatment with lorazepam and aripiprazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Anxiety Agents; Anti-HIV Agents; Antipsychotic Agents; Aripiprazole; Catatonia; Humans; Lorazepam; Male; Piperazines; Psychotic Disorders; Quinolones | 2005 |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Ethambutol; Evaluation Studies as Topic; Fluoroquinolones; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolones | 1993 |
Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ceftazidime; Cephalosporins; Diarrhea; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Histiocytes; Histiocytosis; Humans; Hypersplenism; Male; Penicillanic Acid; Penicillins; Phagocytosis; Piperacillin; Quinolones; Splenic Infarction; Splenomegaly; Tazobactam | 2001 |
[Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; In Vitro Techniques; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Opportunistic Infections; Quinolones; Rifabutin; Rifamycins | 1992 |
[Activity of antibiotics against pigmented and unpigmented variants of Mycobacterium avium-intracellulare].
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Lactams, Macrocyclic; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Opportunistic Infections; Quinolones | 1991 |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Azithromycin; Cell Division; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; In Vitro Techniques; Leprostatic Agents; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 1991 |
Clinical results using two new antibiotics--clarithromycin and temafloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Bacterial Infections; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Opportunistic Infections; Quinolones | 1991 |